It is a pharma private limited company based in Surat, Gujarat, India, established in 2022.
2022 | Surat, Gujarat, India | ActiveRaxia Pharmaceutical Private Limited, a active private limited company, was established on 18 February 2022 in Surat, Gujarat, India. Engaging in pharmaceutical retailers & distributors within the pharma sector, it holds CIN: U24230GJ2022PTC129496. Registered under ROC Roc Ahmedabad. it is unlisted. It has an authorized capital of ₹1.00 M and a paid-up capital of ₹1.00 M.
Its leadership includes Mayur Parshottambhai Khadsaliya (Director), Rita Piyushbhai Khadsaliya (Director), Piyushkumar Parsottambhai Khadsaliya (Director). Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at Shop No. F-19, Sunrise Residency, Utaran Main Road,, Surat, Gujarat, 394105.
U24230GJ2022PTC129496
129496
18 February 2022
₹1.00 M
₹1.00 M
Roc Ahmedabad
Unlisted
Active
Explore comprehensive insights into Raxia Pharmaceutical Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Mayur Parshottambhai Khadsaliya | Director | 18 Feb 2022 | Current |
| Rita Piyushbhai Khadsaliya | Director | 18 Feb 2022 | Current |
| Piyushkumar Parsottambhai Khadsaliya | Director | 18 Feb 2022 | Current |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Enhance accessibility to Raxia Pharmaceutical's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
Unlock access to Raxia Pharmaceutical's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Reveal ownership structures and financial performance - Get instant access now!
There are no open charges registered against the company as per our records.
Raxia Pharmaceutical has a workforce of 0 employees as of Apr 05, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Raxia Pharmaceutical, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Raxia Pharmaceutical's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
The activity Raxia Pharmaceutical Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was completed.
Raxia Pharmaceutical Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Ahmedabad. was recorded as a recent event.
Mayur Parshottambhai Khadsaliya was appointed as a Director was appointed as a Director on 18 Feb 2022 & has been associated with this company since 3 years 10 months . was recorded as a recent event.
Progress on Rita Piyushbhai Khadsaliya was appointed as a Director was appointed as a Director on 18 Feb 2022 & has been associated with this company since 3 years 10 months . was documented.
Piyushkumar Parsottambhai Khadsaliya was appointed as a Director was appointed as a Director on 18 Feb 2022 & has been associated with this company since 3 years 10 months . was recorded as a recent event.
The activity Raxia Pharmaceutical Private Limited was registered on 18 Feb 2022 with Roc Ahmedabad & aged 3 years 10 months as per MCA records. was completed.
The CIN of Raxia Pharmaceutical Private Limited is U24230GJ2022PTC129496.
Raxia Pharmaceutical Private Limited is headquartered at Shop No. F-19, Sunrise Residency, Utaran Main Road,, Surat, Gujarat, 394105.
Raxia Pharmaceutical Private Limited was incorporated on 18 February 2022.
The current directors of Raxia Pharmaceutical Private Limited are
The primary industry of Raxia Pharmaceutical Private Limited is Pharma.
Raxia Pharmaceutical Private Limited is unlisted.
The authorized capital of Raxia Pharmaceutical Private Limited is ₹1.00 M, and the paid-up capital is ₹1.00 M.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX